[{"Assets_0_Q3_USD":64662000000.0,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.52,"CommonStockDividendsPerShareDeclared_3_Q3_USD":1.56,"CommonStockSharesOutstanding_0_Q3_shares":1307000000.0,"EarningsPerShareBasic_1_Q3_USD":2.08,"EarningsPerShareBasic_3_Q3_USD":6.5,"EarningsPerShareDiluted_1_Q3_USD":2.06,"EarningsPerShareDiluted_3_Q3_USD":6.44,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":9145000000.0,"NetIncomeLoss_1_Q3_USD":2718000000.0,"NetIncomeLoss_3_Q3_USD":8493000000.0,"StockholdersEquity_0_Q3_USD":24845000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1319000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1319000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1306000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1307000000.0,"Ticker":"GILD","CIK":"882095","name":"GILEAD SCIENCES INC","OfficialName":"Gilead Sciences Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"78838305412.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20171107"}]